Foff Erin Pennock has filed 18 insider transactions across 1 company since October 2025.
Most recent transaction: a sale of 4321 shares of MapLight Therapeutics, Inc. ($MPLT) on May 07, 2026.
Activity breakdown: 0 open-market purchases and 13 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 4321 | $28.52 | 346,176.0000 | 45,373,033 | 1.23% | 0.01% |
| May 7, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 117 | $29.10 | 346,059.0000 | 45,373,033 | 0.03% | 0.00% |
| May 4, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 5460 | $28.37 | 386,137.0000 | 45,373,033 | 1.39% | 0.01% |
| May 4, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 9180 | $27.50 | 391,597.0000 | 45,373,033 | 2.29% | 0.02% |
| May 4, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 312 | $29.56 | 385,825.0000 | 45,373,033 | 0.08% | 0.00% |
| May 4, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 700 | $30.08 | 385,125.0000 | 45,373,033 | 0.18% | 0.00% |
| May 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 9645 | $28.12 | 375,480.0000 | 45,373,033 | 2.50% | 0.02% |
| May 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 931 | $29.00 | 374,549.0000 | 45,373,033 | 0.25% | 0.00% |
| May 6, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 8152 | $28.04 | 366,397.0000 | 45,373,033 | 2.18% | 0.02% |
| May 6, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 15900 | $29.13 | 350,497.0000 | 45,373,033 | 4.34% | 0.04% |
| April 16, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 881 | $27.49 | 400,777.0000 | 45,373,033 | 0.22% | 0.00% |
| April 15, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 2044 | $26.84 | 401,946.0000 | 45,373,033 | 0.51% | 0.00% |
| April 16, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 288 | $27.01 | 401,658.0000 | 45,373,033 | 0.07% | 0.00% |
| Feb. 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | A | Voting Common Stock | 13360 | $0.00 | 403,835.0000 | 45,373,033 | 3.42% | 0.03% |
| Feb. 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | A | Employee Stock Option (right to buy) | 54240 | $0.00 | 54,240.0000 | 45,373,033 | 9999.99% | 0.12% |
| Jan. 27, 2026 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | F | Voting Common Stock | 44616 | $17.98 | 390,475.0000 | 45,373,033 | 10.25% | 0.10% |
| Oct. 27, 2025 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | A | Employee Stock Option (right to buy) | 196035 | $0.00 | 196,035.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | MapLight Therapeutics, Inc. | $MPLT | Foff Erin Pennock | Chief Medical Officer | A | Voting Common Stock | 48275 | $0.00 | 48,275.0000 | 0 | 9999.99% | 0.00% |